Valbenazine Improves Tardive Dyskinesia with or Without Concomitant Antipsychotic Therapy: A Meta-Analysis of Three Long-Term Valbenazine Trials
Sign Up to like & getrecommendations! Published in 2024 at "CNS Spectrums"
DOI: 10.1017/s1092852924001883
Abstract: Introduction Valbenazine is a highly selective vesicular monoamine transporter 2 inhibitor indicated for tardive dyskinesia (TD), a persistent and potentially debilitating movement disorder associated with prolonged antipsychotic exposure. Given the paucity of data regarding the… read more here.
Keywords: meta analysis; long term; term valbenazine; analysis ... See more keywords